Cargando…

Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci

Vancomycin-resistant enterococci (VRE) account for a large proportion of hospital-acquired infections. Determining optimal treatment of VRE urinary tract infections (UTIs) is challenging. The purpose of this study was to determine if a difference in efficacy or safety exists between linezolid and no...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wingler, Mary Joyce, Patel, Neel R., King, S. Travis, Wagner, Jamie L., Barber, Katie E., Stover, Kayla R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628880/ https://www.ncbi.nlm.nih.gov/pubmed/34842791 http://dx.doi.org/10.3390/pharmacy9040175

Ejemplares similares

1470. Linezolid for Treatment of Urinary Tract Infections Caused by Vancomycin-resistant Enterococci
por: Pontefract, Benjamin, et al.
Publicado: (2019)

597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
por: Wingler, Mary Joyce B, et al.
Publicado: (2018)

Linezolid to treat urinary tract infections caused by vancomycin-resistant Enterococcus
por: Pontefract, Benjamin Alan, et al.
Publicado: (2020)

Optimization of Linezolid Dosing Regimens for Treatment of Vancomycin-Resistant Enterococci Infection
por: Santimaleeworagun, Wichai, et al.
Publicado: (2021)

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

1512. Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population: A Retrospective Cohort Analysis
por: Gunter, Sarah G, et al.
Publicado: (2019)

Analysis of the Clinical Impact of the BioFire FilmArray Meningitis Encephalitis Panel on Antimicrobial Use and Duration of Therapy at an Academic Medical Center
por: Markovich, Kylie, et al.
Publicado: (2022)

Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application
por: Barber, Katie E., et al.
Publicado: (2016)

An evaluation of antipseudomonal dosing on the incidence of treatment failure
por: Hawkins, Brandon K, et al.
Publicado: (2021)

Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
por: Gunter, Sarah Grace, et al.
Publicado: (2022)

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
por: McKinnell, James A., et al.
Publicado: (2015)

Factorial design and post-antibiotic sub-MIC effects of linezolid combined with fosfomycin against vancomycin-resistant enterococci
por: Yan, Yisong, et al.
Publicado: (2022)

Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance
por: Gawryszewska, I., et al.
Publicado: (2017)

Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
por: Kainer, Marion A., et al.
Publicado: (2007)

Vancomycin-resistant enterococci: eradication using vancomycin?
por: Van Prehn, J, et al.
Publicado: (2014)

Validating a screening agar for linezolid-resistant enterococci
por: Werner, Guido, et al.
Publicado: (2019)

Emergence of vancomycin-resistant enterococci.
por: Rice, L B
Publicado: (2001)

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci
por: Kara, Ahu, et al.
Publicado: (2014)

Approach to fever in patients with neutropenia: a review of diagnosis and management
por: Keck, J. Myles, et al.
Publicado: (2022)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
por: Shlezinger, Mor, et al.
Publicado: (2019)

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
por: Qi, Caifen, et al.
Publicado: (2019)

Nosocomial Infection with Vancomycin-dependent Enterococci
por: Tambyah, Paul A., et al.
Publicado: (2004)

Vancomycin-resistant Enterococci, Mexico City
por: Cuellar-Rodríguez, Jennifer, et al.
Publicado: (2007)

Linezolid vs Vancomycin in Induced Thrombocytopenia
por: Al-Harbi, Dimah, et al.
Publicado: (2022)

Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
por: Keck, J. Myles, et al.
Publicado: (2023)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
por: Chitnis, Sheetal, et al.
Publicado: (2013)

Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients
por: Rac, Hana, et al.
Publicado: (2017)

Economic burden of nosocomial infections caused by vancomycin-resistant enterococci
por: Puchter, Laura, et al.
Publicado: (2018)

Molecular Characterization of Virulence Genes in Vancomycin-Resistant and Vancomycin-Sensitive Enterococci
por: Biswas, Priyanka Paul, et al.
Publicado: (2016)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
por: Mühlberg, Eric, et al.
Publicado: (2020)

Fecal colonization with vancomycin-resistant enterococci in Australia.
por: Padiglione, A A, et al.
Publicado: (2000)

Involving ornithologists in the surveillance of vancomycin-resistant enterococci.
por: Sellin, M, et al.
Publicado: (2000)

Excretion of Vancomycin-Resistant Enterococci by Wild Mammals
por: Mallon, David J. P., et al.
Publicado: (2002)

Experience report on surveillance of vancomycin-resistant enterococci
por: Baraldi, MM, et al.
Publicado: (2011)

Genotyping of Vancomycin Resistant Enterococci in Arak Hospitals
por: Hoseini Zadeh, Adeleh, et al.
Publicado: (2015)

Alternatives to Fight Vancomycin-Resistant Staphylococci and Enterococci
por: Baëtz, Benjamin, et al.
Publicado: (2021)

Linezolid- and Multidrug-Resistant Enterococci in Raw Commercial Dog Food, Europe, 2019–2020
por: Freitas, Ana R., et al.
Publicado: (2021)

Genomic Insights to Control the Emergence of Vancomycin-Resistant Enterococci
por: Howden, Benjamin P., et al.
Publicado: (2013)

Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
por: Chastain, Daniel B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6j0tve371nnu8tgueq6o2rs497